Given plasma BDNF’s increased levels in MCI, along with its positive association with hs-CRP, and inverse associations with multiple neurocognitive domains, our data support the hypothesis that increased peripheral BDNF acts as a compensatory mechanism in the preclinical stage of dementia [14, 15]. The gene discussed is BDNF; the disease is dementia.